People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Juva Life, Inc. | — | Pharmaceuticals | Series A | $5.4M | $168.8M | 2018 |
| JUVA LIFE INC./Canada | — | Biotechnology | Pre-Seed | $208K | $7.7M | 2021 |
Douglas Chloupek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Chloupek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mathew Lee | 2 | 6 |
| Rakesh Patel | 2 | 5 |
| Norton Singhavon | 1 | 3 |
| Neil Ruditsky | 1 | 1 |
| Thomas Leschak | 1 | 1 |
| Kari Gothie | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.